Shire Plc Share Price (SHP) - Buy SHP Shares

Shire plc, formerly known as Shire Ltd, is a specialist pharmaceutical company that has a vested interest in the areas of Attention Deficit Hyperactivity Disorder, novel genetic therapies and gastrointestinal diseases. Founded in 1986, the company primarily concentrated on the prevention and treatment of osteoporosis before branching out into other neglected medical areas. Today Shire is considered to have global significance with regards to the pharmaceutical industry and its main products now target the US, Canada, the UK and Europe. Shire also has distributors throughout the rest of the world. The company already has a range of highly effective drug products on the market and are committed to further improvement of novel therapeutics which are already in the late stages of their development.

The company's main areas of expertise lie in product development and risk management and by successfully merging with 7 large companies over the last ten years, Shire has become one of the fastest growing pharmaceutical companies to date. In 1997 they acquired both Pharmavene Inc and Richwood Pharmaceutical Company Inc. Then in 1999 Shire Ltd merged with the global leader Fuisz Technologies and Roberts Pharmaceutical Corporation. Today, their share price reflects their successful growth. Shire Ltd has its global headquarters in the UK with an additional headquarters in the US – the two countries that make most use of the companies approved products. Other offices have been opened around the world over the last few years so that the majority of the products Shire Ltd promotes are now available in over 40 countries.